Role of antimicrobial photodynamic therapy in reducing whole salivary oral yeasts colonization in type-2 diabetic and non-diabetic patients with and without dental implants

被引:5
|
作者
Labban, Nawaf [1 ]
Alfouzan, Afnan F. [1 ]
Al Taweel, Sara Mohammad [1 ]
ALRabiah, Mohammed A. [1 ]
Assery, Mansour K. [2 ]
机构
[1] King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, POB 60169, Riyadh 11545, Saudi Arabia
[2] Riyadh Elm Univ, Dept Prosthodont, Riyadh, Saudi Arabia
关键词
Antimicrobial photodynamic therapy; Candida; Type-2 diabetes mellitus; Oral yeasts; Unstimulated whole saliva; CANDIDA-ALBICANS; SPECIES PREVALENCE; CHRONIC PERIODONTITIS; GUTKA-CHEWERS; CARRIAGE; MELLITUS; CIGARETTE; BIOFILMS; SMOKERS;
D O I
10.1016/j.pdpdt.2021.102183
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim was to assess the impact of antimicrobial photodynamic therapy (aPDT) in reducing whole salivary oral yeasts colonization in type-2 diabetic and non-diabetic patients with dental implants. Methods: Type-2 diabetic and self-reported non-diabetic patients were included. Participants were divided into the following groups: Group-1: Type-2 diabetic patients with dental implants; Group-2: Non-diabetic patients with dental implants; Group-3: Type-2 diabetic patients without dental prostheses; Group-4: Non-diabetic pa-tients without dental prostheses. In each group, participants were subdivided into 2-sub-groups. In the test-subgroup, participants received routine oral hygiene maintenance instructions (OHMI) and underwent full mouth disinfection using aPDT; and in the control-group, participants received OHMI alone. Unstimulated whole saliva samples were collected, hemoglobin A1c levels were measured and yeast colonization was assessed at baseline and at 3-months' follow-up in all groups. Sample-size estimation was done and group-comparisons were done. P-values <0.01 were considered statistically significant. Results: At baseline, the mean oral yeasts colonization was significantly higher among patients in Group-1 (P < 0.001) and 3 (P < 0.001) compared with individuals in groups 2 (P < 0.001) and 4 (P < 0.001). At baseline and at 3-months of follow-up, the mean HbA1c levels and oral yeasts colonization were significantly higher among patients in Group-1 (P < 0.001) and 3 (P < 0.001) compared with individuals in groups 2 (P < 0.001) and 4 (P < 0.001). Conclusion: In the short-term, routine OHMI with adjunct aPDT is more effective in reducing whole salivary oral yeasts counts than OHMI alone in patients with and without dental implants.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Compare and Correlate the Presence of Bacterial Pathogen Concentrations and Glycaemic Status in Type 2 Diabetic and Non-Diabetic Patients with Chronic Periodontitis Following Phase 1 Therapy
    Lakhani, Amit
    Sharma, Ena
    Sachdeva, Surinder
    Thind, Supreet
    Chaudhary, Karun
    Kapila, Savita
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (52): : 3977 - 3983
  • [32] Vascular risk profile and survival rate in dialysis-dependent type 2-diabetic patients aged &gt; 50 years with and without diabetic nephropathy and in age-matched non-diabetic patients on dialysis
    Schmekal, B
    Janko, O
    Hubmann, R
    Biesenbach, G
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 2000, 29 (06) : 227 - 232
  • [33] MORNING OR BED-TIME INSULIN WITH OR WITHOUT GLIBENCLAMIDE IN ELDERLY TYPE-2 DIABETIC-PATIENTS UNRESPONSIVE TO ORAL ANTIDIABETIC AGENTS
    NISKANEN, L
    LAHTI, J
    UUSITUPA, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1992, 18 (03) : 185 - 190
  • [34] Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in non-diabetic patients:: influence of high C-reactive protein level
    Elbaz, M
    Piot, C
    Maupas, E
    Asmar, A
    Perret, B
    Cambou, JP
    Carrié, D
    Puel, J
    EUROPEAN HEART JOURNAL, 2003, 24 : 675 - 675
  • [35] RESIDUAL EFFECTS OF A SHORT-TERM INTENSIFIED INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH ORAL-DRUG FAILURE
    FERY, F
    DESIR, D
    MOCKEL, J
    DIABETES & METABOLISM, 1991, 17 (06): : 525 - 529
  • [36] Hypoglycaemia is Associated to Co-Morbid Vascular Disease in Type-2 Diabetic Patients on Oral Antidiabetic Therapy - An Analysis of the Diaregis Registry
    Gitt, Anselm K.
    Bramlage, Peter
    Binz, Christiane
    Krekler, Michael
    Plate, Tanja
    Loebner, Kristian
    Deeg, Evelin
    Tschoepe, Diethelm
    CIRCULATION, 2010, 122 (21)
  • [37] INSULIN THERAPY IN OVERWEIGHT TYPE-2 (NON-INSULIN DEPENDENT) DIABETIC-PATIENTS - AN ASSOCIATION WITH HIGHER PREVALENCE OF RETINOPATHY
    SEGHIERI, G
    DEGIORGIO, LA
    BARTOLOMEI, G
    ALESSANDRI, GD
    VENTURINO, G
    GIRONI, A
    MAMMINI, P
    DIABETOLOGIA, 1984, 27 (02) : A331 - A331
  • [38] Diabetes mellitus type 2 patients exhibit more pronounced decrease of trigylcerides during statin therapy in comparison to non-diabetic ones
    Lietava, J
    Kosmálová, V
    HYPERTENSION, 2004, 44 (04) : 572 - 572
  • [39] ONE YEAR RESPONSE TO COMBINATION THERAPY WITH BEDTIME INSULIN AND ORAL-AGENTS IN POORLY CONTROLLED TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    SANE, TA
    HELVE, E
    YKIJARVINEN, H
    TASKINEN, MR
    DIABETOLOGIA, 1989, 32 (07) : A537 - A537
  • [40] INSULIN THERAPY IN OBESE AND LEAN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS RESTORES SENSIBILITY TO ORAL-DRUGS AFTER SECONDARY FAILURE
    TORELLA, R
    COZZOLINO, D
    SALVATORE, T
    GIUGLIANO, D
    DONOFRIO, F
    DIABETOLOGIA, 1988, 31 (07) : A550 - A550